NCT01646697View on ClinicalTrials.gov

Slide Interpretation or Standard Surgical Pathology in Assessing Margin Status in Patients With Pancreatic Cancer Undergoing Surgery

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

November 7, 2011

Primary Completion Date

February 6, 2016

Study Completion Date

February 6, 2016

Conditions
Pancreatic CancerAdenocarcinoma
Interventions
OTHER

cytology specimen collection procedure

Undergo cytopathologic sample collection

Trial Locations (1)

43210

Ohio State University Medical Center, Columbus

All Listed Sponsors
lead

Ohio State University Comprehensive Cancer Center

OTHER

NCT01646697 - Slide Interpretation or Standard Surgical Pathology in Assessing Margin Status in Patients With Pancreatic Cancer Undergoing Surgery | Biotech Hunter | Biotech Hunter